The company has no debt and 14 patents for a whole range of uses. In a worst case scenario (imo), it could be put up for auction and surely somebody will have it all for multiples of its current market capitalisation - after all it is a functional mTOR inhibitor with very low adverse effects, an excellent safety profile - look up mTOR inhibitors and their uses.
So either this will be a block buster or a decent earner.
(All my unsound opinion of course and don't bet your future financial life on it or any one stock)
The company has no debt and 14 patents for a whole range of...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.5¢ |
Change
0.005(2.78%) |
Mkt cap ! $73.24M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 19.0¢ | 18.0¢ | $157.8K | 864.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 192000 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.5¢ | 73740 | 1 |
View Market Depth
| Last trade - 16.10pm 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
18.5¢ |
Change
0.005 ( 2.78 %) |
||||
| Open | High | Low | Volume | ||
| 18.0¢ | 19.0¢ | 18.0¢ | 248618 | ||
| Last updated 15.45pm 30/05/2024 ? | |||||
| PAA (ASX) Chart |